Viking Global Investors
Private equity
Active
Greenwich, United States
171
121M
104
6.84
39
0.39
25
- Stages of investment
- Areas of investment
Summary
Viking Global Investors appeared to be the Corporate Investor, which was created in 1999. The main department of described Corporate Investor is located in the Greenwich. The venture was found in North America in United States.
The top amount of exits for fund were in 2019. Comparing to the other companies, this Viking Global Investors performs on 11 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. When the investment is from Viking Global Investors the average startup value is more than 1 billion dollars. Deals in the range of more than 100 millions dollars are the general things for fund. The real fund results show that this Corporate Investor is 18 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2019.
The overall number of key employees were 1.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Moderna Therapeutics, Roivant Sciences, Credit Karma. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Agriculture, Genetics.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Viking Global Investors, startups are often financed by Illumina Accelerator, Felicis Ventures, Tenaya Capital. The meaningful sponsors for the fund in investment in the same round are Perceptive Advisors, Wellington Management, T. Rowe Price. In the next rounds fund is usually obtained by Y Combinator, Senator Investment Group, SVG Ventures.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 171
- Lead investments
- 39
- Exits
- 25
- Rounds per year
- 6.84
- Follow on index
- 0.39
- Investments by industry
- Biotechnology (103)
- Health Care (54)
- Therapeutics (32)
- Medical (31)
- Pharmaceutical (28) Show 108 more
- Investments by region
-
- United States (145)
- United Kingdom (5)
- Canada (6)
- China (2)
- Mexico (2) Show 5 more
- Peak activity year
- 2021
- Number of Unicorns
- 18
- Number of Decacorns
- 18
- Number of Minotaurs
- 9
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 727M
- Group Appearance index
- 0.95
- Avg. company exit year
- 6
- Avg. multiplicator
- 5.03
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Astarte Medical | 07 May 2019 | Analytics, Health Care, Health Diagnostics, Medical, Predictive Analytics | Early Stage Venture | 5M | United States, Pennsylvania |
Diagonal Therapeutics | 03 Apr 2024 | Early Stage Venture | 128M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.